Latest research confirms genetic susceptibility to lung cancer
Key points
- Previous research has shown that Asian patients with lung cancer are more likely to harbor epidermal growth factor receptor (EGFR) mutations.
- Researchers looked at the genetics of 716 Japanese patients with lung cancer and 716 without.
- The study also suggests that "a suggestive difference in the impact of rs16969968 and rs8034191 on the 15q25 loci by EGFR status on lung cancer risk."
- The authors conclude that the 15q25 genetic region should be studied further.
Previous research has shown that Asian patients with lung cancer are more likely to harbor epidermal growth factor receptor (EGFR) mutations. Furthermore, Asian patients with lung cancer are more likely to be non-smokers than Western patients with lung cancer. Research in the May 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology goes deeper, investigated genetic factors and smoking exposure in Japanese lung cancer patients.
Researchers looked at the genetics of 716 Japanese patients with lung cancer and 716 without. They found, "the variants rs12914385, rs1317286 and rs931794 localized to the CHRNA5-CHRNA3-CHRNB4 cluster on chromosome 15q25 modified the impact of cigarette smoking on lung cancer risk, but showed no statistically significant major effect on the risk of lung cancer." They conclude that there is a significant difference in the impact of smoking on lung cancer risk among former smokers between those with and without genetic risk.
The study also suggests that "a suggestive difference in the impact of rs16969968 and rs8034191 on the 15q25 loci by EGFR status on lung cancer risk."
The authors conclude that the 15q25 genetic region should be studied further.
The lead author of this work is Dr. Hidemi Ito. IASLC member co-authors include Dr. Yasushi Yatabe and Dr. Tetsuya Mitsudomi.
###
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 3,500 lung cancer specialists in 80 countries. To learn more about IASLC please visit www.iaslc.org.
###
Contact: Kristal Griffith
[email protected]
720-325-2952
International Association for the Study of Lung Cancer
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNew breast cancer genetics research from McGill University, Department of Human Genetics discussed
New research, 'Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent,' is the subject of a report (see also Breast-Cancer-Genetics.html">Breast…
23 May 2008
NewsIt's time to consider propranolol as an anti-cancer drug, researchers say
Propranolol , a beta-blocker commonly prescribed to treat irregular heart rates and other conditions, has significant anti-cancer properties, say researchers in a new clinical study published in ecancermedicalscience.…
14 October 2016
NewsResearchers take first step in precision medicine for penile cancer
Researchers have identified potential genetic alterations in penile cancer that could pave the way for targeted treatments. For many patients with this rare cancer, surgery is all that's needed. But in aggressive forms…
